<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[commercialization Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/commercialization.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to commercialization]]></description>
	<s:counts start="0" returned="20" found="179" />
	<language>en-us</language>
	<item>
		<title><![CDATA[SulphCo, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14034_23-327473.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator instructions Our first question comes from David Firshein of Cascade Capital Corporation. Please go ahead. David Firshein &#8211; Cascade Capital Corporation Larry, guys, good, very good report and good luck with it. My questions are focused on any sort of gauge of actual revenue events...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Sat, 01 Aug 2009 02:36:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[Commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/sulphco+inc..html"><![CDATA[Sulphco Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SUF</category>
		<category domain="tickers">SUF</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. F4Q and Full Year 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-275019.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Liana Moussatos of Wedbush Morgan. Liana Moussatos - Wedbush Morgan  Could you repeat the quarter-over-quarter AzaSite sales and prescription growth and then what was the stock based compensation amount?  Also, how many potential partners are in discussion...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 03 Mar 2009 12:30:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[Commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/elestat.html"><![CDATA[Elestat]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[EMD Serono Snags US license for Tesamorelin From Theratechnologies]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F103241-emd-serono-snags-us-license-for-tesamorelin-from-theratechnologies%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits:   Theratechnologies and EMD Serono, US arm of Merck KGaA (MKGAY.PK), announced they have entered into a collaboration and licensing agreement for the exclusive commercialization rights to tesamorelin in the United States for the treatment of excess abdominal fat in HIV patients with lipodystrophy. Theratechnologies retains all...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 31 Oct 2008 03:44:29 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[Commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/serono+s.a..html"><![CDATA[Serono S.A.]]></category>
		<category domain="http://resources.bnet.com/topic/hiv+virus.html"><![CDATA[HIV Virus]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/tesamorelin.html"><![CDATA[Tesamorelin]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/theratechnologies.html"><![CDATA[Theratechnologies]]></category>
		<category domain="http://resources.bnet.com/topic/service+management.html"><![CDATA[Service Management]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
	</item>
	<item>
		<title><![CDATA[Arizona State University Taps Impress Public Relations to Support Flexible Display Center]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_27/ai_n30937647]]></link>
		<description><![CDATA[PHOENIX -- Impress Public Relations, Inc., an international B2B agency, has been named agency of record for the Flexible Display Center at Arizona State University ("FDC"). The FDC is a partnership of ASU, the U.S. Army and private industry for the purpose of advancing development and commercialization of flexible display...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 27 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[agency]]></category>
		<category domain="http://resources.bnet.com/topic/arizona+state+university.html"><![CDATA[Arizona State University]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/electronics.html"><![CDATA[electronics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[partnership]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+army.html"><![CDATA[U.S. Army]]></category>
	</item>
	<item>
		<title><![CDATA[T-Ray Science, Inc.: Dr. Daryoosh Saeedkia Awarded 2008 Douglas R. Colton Medal for Research Excellence]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200810/ai_n30899970]]></link>
		<description><![CDATA[T-Ray Science, Inc., ("T-Ray", the "Company") an emerging leader in the field of TeraHertz ("THz") research, is pleased to announce that our Chief Technology Officer, Dr. Daryoosh Saeedkia, was awarded the prestigious 2008 Douglas R. Colton Medal for Research Excellence from CMC Microsystems.  The Douglas R. Colton Medal for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 16 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+waterloo.html"><![CDATA[University of Waterloo]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CytRx Corporation's 45% Owned Affiliate RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachusetts Medical School]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_15/ai_n30894417]]></link>
		<description><![CDATA[RXi Plans to Develop Oral rxRNA[TM] Therapeutics for Inflammatory Diseases  LOS ANGELES -- CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that its 45% owned affiliate RXi Pharmaceuticals Corporation has licensed exclusive worldwide rights from the University of Massachusetts Medical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/cytrx+corp..html"><![CDATA[CytRx Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+massachusetts.html"><![CDATA[University of Massachusetts]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTR</category>
		<category domain="tickers">CYTR</category>
	</item>
	<item>
		<title><![CDATA[RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachusetts Medical School]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_14/ai_n30891394]]></link>
		<description><![CDATA[Company Plans to Develop Oral rxRNA[TM] Therapeutics for Inflammatory Diseases  WORCESTER, Mass. -- RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference RNAi, today announced that it has licensed exclusive worldwide rights from the University of Massachusetts Medical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 14 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+massachusetts.html"><![CDATA[University of Massachusetts]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pluristem Therapeutics Announces US$1 Million Sale of Shares at 44% Premium to Market Price]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_23/ai_n28575790]]></link>
		<description><![CDATA[NEW YORK -- Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized allogeneic cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced it has entered into definitive agreements to sell common stock and warrants for aggregate gross proceeds of $1,035,000....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 23 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[VIVUS Announces Date of Second Quarter 2008 Financial Results and Conference Call]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_31/ai_n27965193]]></link>
		<description><![CDATA[MOUNTAIN VIEW, Calif. -- VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the quarter ended June 30, 2008 after the NASDAQ Market closes on Monday August 4, 2008. The company will conduct...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Halcyon Products&#39; FireGround Compass(R) Receives Acceptance of Department of Homeland Security&#39;s TechSolutions Program]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200806/ai_n27881528]]></link>
		<description><![CDATA[Halcyon Products, Inc. announces that their newly developed product, the FireGround CompassŪ, has completed the TechSolutions rapid prototyping and operational testing process.  The TechSolutions Program recently announced the Halcyon FireGround CompassŪ as the first product designed by a first responder, to have surpassed the entire TechSolutions development path and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 26 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/engineering.html"><![CDATA[Engineering]]></category>
		<category domain="http://resources.bnet.com/topic/firefighter.html"><![CDATA[firefighter]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/productivity.html"><![CDATA[PRODUCTIVITY]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+homeland+security.html"><![CDATA[U.S. Department of Homeland Security]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pluristem's President & CEO to be Keynote Speaker at The 4th Annual Stem Cells Asia Congress]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_23/ai_n27504022]]></link>
		<description><![CDATA[NEW YORK -- Pluristem Therapeutics Inc. (NASDAQ: PSTI) (DAX: PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized allogeneic cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that Mr. Zami Aberman, Pluristem's President & CEO, will be the keynote speaker at the 4th...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 23 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/3d.html"><![CDATA[3D]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/president.html"><![CDATA[president]]></category>
		<category domain="http://resources.bnet.com/topic/speaker.html"><![CDATA[speaker]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
	</item>
	<item>
		<title><![CDATA[The Institute for Technology Entrepreneurship & Commercialization  at Boston University Announces $50K Business Plan Competition Winners]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_14/ai_n25152003]]></link>
		<description><![CDATA[BOSTON -- The Institute for Technology Entrepreneurship & Commercialization ITEC at Boston University today announced the three winners of its 2008 $50K Business Plan Competition. The eighth annual competition showcased diverse and innovative life science, medical and mobile technologies, as well as language lesson products. This year's team winners were:]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/boston+university.html"><![CDATA[Boston University]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[Commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25270491]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 April 2008-RealPennies.com: Turning Pennies into  dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).C1994-2008 M2  COMMUNICATIONS LTD     RDATE:02042008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559     For more info: http://cege.realpennies.com ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/cell+genesys+inc..html"><![CDATA[Cell Genesys Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mphase+technologies+inc..html"><![CDATA[mPhase Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CEGE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XDSL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CEGE,XDSL,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock Alert.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25269923]]></link>
		<description><![CDATA[M2 PRESSWIRE-1 April 2008-otcstockexchange.com: STHG, CEGE, ACUS,  XDSL - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS  LTD    RDATE:01042008    Rochester, NY -- OTCStockExchange.com's "Stock Watch  Alert" this morning are Steadfast Holdings Group, Inc. (Pink  Sheets: STHG), Cell Genesys, Inc. (Nasdaq: CEGE), Acusphere Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/dsl.html"><![CDATA[DSL]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mphase+technologies+inc..html"><![CDATA[mPhase Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/takeda.html"><![CDATA[Takeda]]></category>
		<category domain="http://resources.bnet.com/topic/telecommunications.html"><![CDATA[TELECOMMUNICATIONS]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XDSL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">XDSL,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Small Cap Stocks to Watch - CEGE, ITMN, IMAX, TWTI.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25270197]]></link>
		<description><![CDATA[M2 PRESSWIRE-1 April 2008-SmallCapReview.com: Small Cap Stocks to  Watch - CEGE, ITMN, IMAX, TWTIC1994-2008 M2 COMMUNICATIONS LTD     RDATE:01042008     To register for the Free SmallCapReview Newsletter and  automatically be entered to win a Blackberry Pearl visit  http://www.smallcapreview.com/subscribe.htm   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/processors.html"><![CDATA[Processors]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[MTI Announces Filing of Registration Statement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_27/ai_n24959784]]></link>
		<description><![CDATA[ALBANY, N.Y. -- Mechanical Technology, Incorporated (MTI, Nasdaq: MKTY), a company primarily engaged in the development and commercialization of Mobion([R])off-the-grid portable power solutions, through its subsidiary MTI MicroFuel Cells Inc. MTI Micro, and in the design, manufacture, and sale of test and measurement instruments and systems, through its subsidiary MTI...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[DMC, GSB, AKNS, CPLP, DNDN, NSTK Have Also Been Added To Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25267230]]></link>
		<description><![CDATA[M2 PRESSWIRE-25 March 2008-BUYINS.NET: DMC, GSB, AKNS, CPLP, DNDN,  NSTK Have Also Been Added To Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:25032008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 25 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/databases.html"><![CDATA[Databases]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/storage.html"><![CDATA[Storage]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">DNDN,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[VIVUS Announces Date of Fourth Quarter and Full Year 2007 Financial Results and Conference Call]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_4/ai_n24363642]]></link>
		<description><![CDATA[MOUNTAIN VIEW, Calif. -- VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the quarter and year ended December 31, 2007 after the NASDAQ Market closes on Thursday March 6, 2008. The company...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 04 Mar 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[ABR, SBR, TWP, AGIX, CNLG, NSTK Have Been Removed From Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25258916]]></link>
		<description><![CDATA[M2 PRESSWIRE-3 March 2008-BUYINS.NET: ABR, SBR, TWP, AGIX, CNLG,  NSTK Have Been Removed From Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:03032008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been removed from the NASDAQ, AMEX and NYSE naked short...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Mar 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/atherogenics+inc..html"><![CDATA[AtheroGenics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGIX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">AGIX,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Verenium Awarded U.S. Department of Energy Grant to Speed Enzyme Development for Cellulosic Ethanol Production]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200802/ai_n25308504]]></link>
		<description><![CDATA[To: ENERGY EDITORS Contact: Kelly Lindenboom, Vice President, Corporate Communications of Verenium Corporation, +1-617-674-5335, kelly.lindenboom@verenium.com  CAMBRIDGE, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next- generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded one of four...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 27 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biofuel.html"><![CDATA[biofuel]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+energy.html"><![CDATA[U.S. Department of Energy]]></category>
		<category domain="http://resources.bnet.com/topic/verenium+corp..html"><![CDATA[Verenium Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRNM</category>
		<category domain="tickers">VRNM</category>
	</item>
</channel>
</rss>
